TRAT1 and acute respiratory distress syndrome: At present, no compounds that targeting TRIM proteins have been identified, but it is important to develop the specific inhibitors of TRIM proteins as the therapeutic tools in multiple diseases.8 TRIM47 may be an attractive target for drug development in endothelial inflammation and ALI.